<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34821121</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">2191-0251</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>26</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of pediatric endocrinology &amp; metabolism : JPEM</Title>
          <ISOAbbreviation>J Pediatr Endocrinol Metab</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An unusual presentation of primary adrenal insufficiency with new onset type 1 diabetes: case report and review of the literature.</ArticleTitle>
        <Pagination>
          <StartPage>531</StartPage>
          <EndPage>534</EndPage>
          <MedlinePgn>531-534</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpem-2021-0193</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To describe an atypical presentation of primary adrenal insufficiency in conjunction with new onset type 1 diabetes.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">Here, we describe a case of new-onset type 1 diabetes (T1D) presenting simultaneously with an unusual presentation of primary adrenal insufficiency in a previously healthy 16-year-old. He was admitted for a typical presentation of diabetic ketoacidosis, but with extreme hyponatremia. An extensive workup revealed a low aldosterone level, appropriate cortisol level, and positive 21-hydroxylase antibodies. While the phenomenon of multiple autoimmune conditions developing in the same patient is well-described, this particular case has several atypical aspects. Our patient's case highlights the danger of relying on random serum cortisol in the setting of acute illness to rule out adrenal insufficiency.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Adrenal insufficiency can present as isolated hypoaldosteronism without hypocortisolemia and can manifest as severe hyponatremia in the context of diabetic ketoacidosis. Workup for an unusual presentation of T1D should include a 21-hydroxylase antibody, as well as thyroid and celiac disease studies.</AbstractText>
          <CopyrightInformation>© 2021 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Graf</LastName>
            <ForeName>Shelby</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-6788-4523</Identifier>
            <AffiliationInfo>
              <Affiliation>PGY-3, University of Minnesota Pediatrics, 2450 Riverside Ave., Room M136, 1st Floor, East Building, Minneapolis, MN 55454, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poeppelman</LastName>
            <ForeName>Rachel Stork</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Critical Care, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McVean</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Endocrinology and Diabetes, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rayannavar</LastName>
            <ForeName>Arpana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Endocrinology and Diabetes, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sunni</LastName>
            <ForeName>Muna</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Endocrinology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Pediatr Endocrinol Metab</MedlineTA>
        <NlmUniqueID>9508900</NlmUniqueID>
        <ISSNLinking>0334-018X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 1.14.14.16</RegistryNumber>
          <NameOfSubstance UI="D013255">Steroid 21-Hydroxylase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000224" MajorTopicYN="Y">Addison Disease</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000309" MajorTopicYN="Y">Adrenal Insufficiency</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006994" MajorTopicYN="Y">Hypoaldosteronism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013255" MajorTopicYN="N">Steroid 21-Hydroxylase</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Addison’s disease</Keyword>
        <Keyword MajorTopicYN="N">autoimmune polyglandular syndrome</Keyword>
        <Keyword MajorTopicYN="N">primary adrenal insufficiency</Keyword>
        <Keyword MajorTopicYN="N">type 1 diabetes mellitus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>25</Day>
          <Hour>7</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34821121</ArticleId>
        <ArticleId IdType="doi">10.1515/jpem-2021-0193</ArticleId>
        <ArticleId IdType="pii">jpem-2021-0193</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Erichsen, MM, Løvås, K, Skinningsrud, B, Wolff, AB, Undlien, DE, Svartberg, J, et al.. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 2009;94:4882–90. https://doi.org/10.1210/jc.2009-1368.</Citation>
        </Reference>
        <Reference>
          <Citation>Brewer, KW, Parziale, VS, Eisenbarth, GS. Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency. N Engl J Med 1997;337:202. https://doi.org/10.1056/nejm199707173370314.</Citation>
        </Reference>
        <Reference>
          <Citation>Baker, PR, Nanduri, P, Gottlieb, PA, Yu, L, Klingensmith, GJ, Eisenbarth, GS, et al.. Predicting the onset of Addison’s disease: ACTH, renin, cortisol and 21‐hydroxylase autoantibodies. Clin Endocrinol 2012;76:617–24. https://doi.org/10.1111/j.1365-2265.2011.04276.x.</Citation>
        </Reference>
        <Reference>
          <Citation>Betterle, C, Scalici, C, Presotto, F, Pedini, B, Moro, L, Rigon, F, et al.. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988;117:467–75. https://doi.org/10.1677/joe.0.1170467.</Citation>
        </Reference>
        <Reference>
          <Citation>American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010;33(1 Suppl):S11–61. https://doi.org/10.2337/dc10-S004.</Citation>
        </Reference>
        <Reference>
          <Citation>Dittmar, M, Kahaly, GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab 2003;88:2983–92. https://doi.org/10.1210/jc.2002-021845.</Citation>
        </Reference>
        <Reference>
          <Citation>Eisenbarth, GS, Gottlieb, PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068–79. https://doi.org/10.1056/nejmra030158.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
